What is Shanghai Haoyuan Chemexpress Co., Ltd.'s (688131.SS) StockRank?

MoatMap's StockRank for Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) is 50/100, with a Hold signal. This is a composite score combining Quality (57), Value (16), and Momentum (67) factor ranks across MoatMap's 19,000+ stock universe.

Does Shanghai Haoyuan Chemexpress Co., Ltd. have an economic moat?

Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shanghai Haoyuan Chemexpress Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) is Hold, based on a StockRank of 50/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shanghai Haoyuan Chemexpress Co., Ltd. in?

Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688131.SS

HOLDFLAG

Shanghai Haoyuan Chemexpress Co., Ltd. · Healthcare · China · $2.3B · Avg Vol: $63M/d

StockRank

P/E (TTM)

66.0x

ROE

7.5%

D/E

0.7x

Dividend %

0.3%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shanghai Haoyuan Chemexpress is a high-quality CDMO/CRO focused on small molecules and ADC linkers, but geopolitical tensions around Chinese biotech warrant caution.

COMPANY DESCRIPTION

Shanghai Haoyuan Chemexpress Co., Ltd. provides pharmaceutical R&D and manufacturing services (CRO/CDMO), specializing in small molecule drug discovery. The company's competitive moat lies in its proprietary library of over 100,000 high-quality molecular building blocks and tool compounds. It is a prominent niche player serving global pharmaceutical giants with high customer stickiness.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	201M	278M	336M	425M	28.4%
EPS	0.14	0.09	0.14	0.17	6.0%
Shares	209M	211M	211M	212M	+1.6%
Debt	95M	155M	282M	330M	51.2%
Equity	343M	371M	425M	463M	10.6%
Op CF	-36M	-9M	56M	47M	-16.8%
Inv CF	-105M	-49M	-116M	-30M	—
Fin CF	53M	60M	117M	26M	—

PRICE (1M)+3.0%

SMA 50SMA 200

$11.04

RSI (14)

42.8

52W High

$13.39

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

7.3%64.4

ROE

7.5%64.4

GP/Assets

21.1%48.7

Op. Margin

19.3%81.2

FCF/Assets

2.5%59.8

Piotroski

—83.5

Int. Cover

6.1x57.0

D/E Ratio

0.72x21.3

Current Ratio

2.16x40.1

Value

P/E (TTM)

66.0x14.6

EV/EBITDA

33.9x10.4

P/FCF

685.2x10.9

P/B

5.0x23.8

P/S

5.4x38.5

Div Yield

0.3%7.7

Momentum

52W High %

83%78.2

RS 6M

-9%70.1

SMA 50/200

1.01x64.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+88%68.8

Q Growth

9%50.3

FUNDAMENTALS

Market Cap

$2.3B

P/E (Forward)

35.1x

Gross Margin

44.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688131.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688131.SS	Shanghai Haoyuan Chemexpress Co., Ltd.(you)	$2.3B	50	HOLD
300601.SZ	Shenzhen Kangtai Biological Products Co., Ltd.	$2.1B	51	HOLD
300199.SZ	Hybio Pharmaceutical Co., Ltd.	$3.0B	48	HOLD
603538.SS	Ningbo Menovo Pharmaceutical Co., Ltd.	$1.6B	51	HOLD
300558.SZ	Betta Pharmaceuticals Co., Ltd.	$3.3B	46	HOLD
000534.SZ	Wedge Industrial Co.,Ltd.	$2.5B	39	HOLD
002020.SZ	Zhejiang Jingxin Pharmaceutical Co., Ltd.	$1.7B	57	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
002675.SZ	Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	$1.6B	43	HOLD
002317.SZ	Guangdong Zhongsheng Pharmaceutical Co., Ltd.	$3.0B	60	HOLD

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.1%

Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) — Stock Score Summary

Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) has a MoatMap StockRank of 50/100 based on Quality (57/100), Value (16/100), and Momentum (67/100) factor scores. The current signal is HOLD. Shanghai Haoyuan Chemexpress is a high-quality CDMO/CRO focused on small molecules and ADC linkers, but geopolitical tensions around Chinese biotech warrant caution.

Key Financial Metrics

Price	$11.04
Market Cap	$2.3B
P/E (TTM)	65.97
P/E (Forward)	35.13
Price/Book	5.01
Return on Equity	7.5%
Return on Invested Capital	7.3%
Debt/Equity	72.34
Gross Margin	44.1%
Operating Margin	19.3%
Revenue Growth	20.2%
Dividend Yield	0.3%
Free Cash Flow	$3M

Shanghai Haoyuan Chemexpress Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai Haoyuan Chemexpress Co., Ltd.’s (688131.SS) StockRank?: MoatMap’s StockRank for Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) is 50/100, with a Hold signal. It is a composite of Quality (57), Value (16), and Momentum (67) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shanghai Haoyuan Chemexpress Co., Ltd. have an economic moat?: Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai Haoyuan Chemexpress Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) is Hold, based on a StockRank of 50/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai Haoyuan Chemexpress Co., Ltd. in?: Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).